The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 331:918-921 October 6, 1994 Number 14
NextNext

Enhanced Humoral Immunity in Common Variable Immunodeficiency after Long-Term Treatment with Polyethylene Glycol-Conjugated Interleukin-2
Charlotte Cunningham-Rundles, Kasim Kazbay, Joe Hassett, Zhuo Zhou, and Lloyd Mayer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Common variable immunodeficiency is a primary immunodeficiency disease characterized by low serum concentrations of IgG, IgA, and usually IgM1,2. Although some patients appear to have only intrinsic B-cell defects, more than half also have abnormalities of T-cell activation and deficient secretion of interferon-{gamma} and interleukin-2, -4, and -53,4,5,6,7. Most patients also have deficient production of a B-cell differentiation factor, a 34-kd protein that has been purified and lacks interleukin-2, -4, -6, and -10 activity8. We and others hypothesized that the B cells in this disease may be defective because of a lack of essential cytokines9,10,11,12. Because . . . [Full Text of this Article]

Case Report

Methods

Protocol for PEG-Conjugated Interleukin-2

Lymphocyte Populations and Proliferation

Assays for Interleukin-2, Interleukin-6, and B-Cell Differentiation Factor

In Vitro Immunoglobulin Production

Serum Immunoglobulins and Antibody Production

Results

Lymphocyte Proliferation

Production of Interleukin-2 and Interleukin-6

B-Cell Differentiation Factor

Serum Immunoglobulins and Antibody Production

Clinical Effect

Discussion


Source Information

From the Division of Clinical Immunology, Department of Medicine, Mount Sinai Medical Center, 1 Gustave Levy Pl., New York, NY 10029, where reprint requests should be addressed to Dr. Cunningham-Rundles.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.